Anthera Pharmaceuticals, Inc. - stock earnings
Stock symbol ANTH is outdated, potentially delisted? Maybe it is available on other exchange?
ANTH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2018Q1 | -7.7 million USD | ? USD |
| 2017Q4 | -9.7 million USD | ? USD |
| 2017Q3 | -6.3 million USD | ? USD |
| 2017Q2 | 313000 USD | ? USD |
ANTH Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2017 | -26.9 million USD | ? USD |
| 2016 | -55.5 million USD | 145000 USD |
| 2015 | -35.2 million USD | 3.2 million USD |
| 2014 | -29.6 million USD | ? USD |
ANTH
Price: -
Earnings Per Share: -0.01 USD
P/E Ratio: 0.00
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Volume: 726
Ebitda: -16.4 millionMarket Capitalization: 6178